Brief: Coherus BioSciences Says Entered Into Exclusive License And Distribution Agreement With Apotex

Coherus Oncology

02/07/2024 14:38

July 2 (Reuters) - Coherus BioSciences Inc  CHRS.O :
    * COHERUS BIOSCIENCES INC - ON JUNE 27, ENTERED INTO AN
EXCLUSIVE
LICENSE AND DISTRIBUTION AGREEMENT WITH APOTEX, INC
    * COHERUS BIOSCIENCES INC - HAS GRANTED TO APOTEX AN
EXCLUSIVE
LICENSE UNDER CO'S RIGHTS TO TORIPALIMAB TO COMMERCIALIZE
TORIPALIMAB WITHIN CANADA
    * COHERUS BIOSCIENCES INC - APOTEX AGREED TO PAY TO COMPANY
AN
UPFRONT PAYMENT OF $6.25 MILLION UNITED STATES DOLLARS
    * COHERUS BIOSCIENCES - APOTEX AGREED TO PAY TO CO USD
EQUIVALENT
OF UP TO AGGREGATE OF UP TO $51.5 MILLION CANADIAN DOLLARS IN
MILESTONE PAYMENTS

Source text for Eikon:  ID:n0001558370-24-009650 
Further company coverage:  CHRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))